Heba Youssef: Can Cefoperazone Cause Coagulopathy?
Heba Youssef, Clinical Nutrition Pharmacist at Helwan General Hospital, shared a post on LinkedIn:
”Cefoperazone can cause a coagulopathy that’s easy to miss. Its NMTT side chain interferes with vitamin K-dependent clotting factors, and in some patients this is made worse by suppression of gut flora that normally produces vitamin K. The result, hypoprothrombinemia, can happen with or without visible bleeding, which is exactly why it needs active monitoring rather than waiting for symptoms.
Patients at higher risk include those with poor nutrition, malabsorption, liver or biliary disease, kidney dysfunction, prolonged or high-dose therapy, or concurrent use of anticoagulants. For these patients, checking baseline and repeat PT/INR and platelet counts is a simple but important safety step.
Giving vitamin K to every patient on cefoperazone isn’t routinely recommended, since the evidence doesn’t support one standard approach. But vitamin K should be given once deficiency or drug-related coagulopathy is suspected or confirmed. A 2024 randomized trial found that 10 mg IV vitamin K weekly reduced coagulopathy and bleeding in high-risk ICU patients, an encouraging finding, though still from a single study rather than an established guideline.
If PT/INR rises unexpectedly during cefoperazone therapy, check for vitamin K deficiency and other causes before blaming the drug alone. And if bleeding continues with no other explanation, that’s a clear signal to stop the drug and follow your institution’s protocol.
References:
- FDA. CEFOBID® (cefoperazone) Prescribing Information. Revised March
- Miao W, Guo J, Cheng H, et al. Risk Factors for Cefoperazone/Sulbactam-Induced Coagulation Disorder. Infect Drug Resist. 2023;16:6277–6284.
- Ebid AI, Abdeen HA, Maher RM, Mohamed-Abdel-Motaleb SM. Cefoperazone-Sulbactam-Induced Coagulopathy in Critically Ill Egyptian Patients: Role of Vitamin K Prophylactic Doses. Hosp Pharm.
- Strom BL, Schinnar R, Gibson GA, Brennan PJ, Berlin JA. Risk of bleeding and hypoprothrombinaemia associated with NMTT side chain antibiotics: using cefoperazone as a test case. Pharmacoepidemiol Drug Saf. ”
Other posts featuring Heba Youssef on Hemostasis Today.
-
Sep 30, 2026, 22:28Recent Mechanical Risk Factors and Young-Onset Cryptogenic Ischemic Stroke – American Heart Association International
-
Sep 30, 2026, 22:22Expert Consensus on Inferior Vena Cava Thrombosis – Thrombosis and Haemostasis Journal
-
Sep 30, 2026, 22:21Markus Abeln: How Platelets, Coagulation, Glycosylation, and Complement Regulate Placental Blood Flow
-
Sep 30, 2026, 22:19Fatma Al Arbawi: Studying Blood Clot Mechanics to Understand Aspirin Resistance and Thrombosis
-
Sep 30, 2026, 22:17Sudhir Kumar: Stroke is a Medical Emergency – and Every Minute Matters
-
Sep 30, 2026, 22:15Luisa Medeiros Visentini: Our Research on Cognitive Impairment After CVT Cited in the International Journal of Stroke
-
Sep 30, 2026, 21:50Jagat Narula: Connecting Cardiovascular Health and Sickle Cell Disease on World Heart Day 2026
-
Sep 30, 2026, 21:38John Kastelein: Exploring the Biology of Cardiovascular Disease at BioCentury Grand Rounds Europe
-
Sep 30, 2026, 21:36Mark Murphy: Irish Heart Foundation Meets With Senator Teresa Costello on World Heart Day